HomeNYSE:PFE

NYSE:PFE

Could Pfizer Stock Be Misjudged by the Market Despite Its Strong Fundamentals?

Could Pfizer Stock Be Misjudged by the Market Despite Its Strong Fundamentals?

September 21, 2022

PFE Stock Price Target Releases Topline Statistics for Children’s Late-Stage EU Trials of the Pneumococcal Vaccination

PFE Stock Price Target Releases Topline Statistics for Children’s Late-Stage EU Trials of the Pneumococcal Vaccination

September 20, 2022

PFE Stock Price Predictions up as Pfizer/Biontech and Moderna Vaccines Get Nod From Eu’s Ema Panel

September 16, 2022

Pfizer Stock up on Late-Stage Trials for New Vaccine

Pfizer Stock up on Late-Stage Trials for New Vaccine

September 15, 2022

Pfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

Pfizer, Biontech, Moderna, Novavax to Gain in Passing of New Law

September 12, 2022

Pfizer and BioNTech’s vaccine for COVID-19 for Children is approved by Canada.

Pfizer and BioNTech’s vaccine for COVID-19 for Children is approved by Canada.

September 9, 2022

Pfizer’s Group B Strep Vaccine Gets FDA Breakthrough Designation

September 7, 2022

Moderna vs. Pfizer, Which COVID Booster Stock Is Better?

Moderna vs. Pfizer, Which COVID Booster Stock Is Better?

August 29, 2022

Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement

Moderna Sues Pfizer And BioNTech Over mRNA Patent Infringement

August 29, 2022

Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines

August 29, 2022

« 1 … 3 4 5 6 »